CKIP-1 regulates macrophage proliferation by inhibiting TRAF6-mediated Akt activation

Cell Research

Volumn 24, Issue 6, 2014, Pages 742-761

  Zhang, Luo ^a,c   Wang, Yiwu ^a   Xiao, Fengjun ^a   Wang, Shaoxia ^a   Xing, Guichun ^a   Li, Yang ^a   Yin, Xiushan ^a   Lu, Kefeng ^a   Wei, Rongfei ^a   Fan, Jiao ^a   Chen, Yuhan ^a   Li, Tao ^d   Xie, Ping ^a   Yuan, Lin ^a   Song, Lei ^a   Ma, Lanzhi ^e   Ding, Lujing ^e   He, Fuchu ^a   Zhang, Lingqiang ^a,b  

^a BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^b DALIAN MEDICAL UNIVERSITY   (China)

^c Beijing 307 Hospital   (China)

^d China National Center of Biomedical Analysis   (China)

^e BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

Akt signaling; CKIP 1; GSK3 ; macrophage proliferation; TRAF6

Indexed keywords

CARRIER PROTEIN; CKIP-1 PROTEIN, MOUSE; COLONY STIMULATING FACTOR 1; CYCLIN D; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; MYC PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

ANIMAL; ANTAGONISTS AND INHIBITORS; APOPTOSIS; BONE MARROW CELL; C57BL MOUSE; CELL CULTURE; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECTS; GENETICS; HUMAN; KNOCKOUT MOUSE; MACROPHAGE; METABOLISM; MOUSE; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; BONE MARROW CELLS; CARRIER PROTEINS; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN D; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-MYC; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 6;

EID: 84901845351     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2014.53     Document Type: Article

References (54)

1. Martinez FO, Helming L, Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 2009; 27:451-483.
2. Hamilton JA. Colony-stimulating factors in inflammation and autoimmunity. Nat Rev Immunol 2008; 8:533-544. (Pubitemid 351913679)
3. Chitu V, Stanley ER. Colony-stimulating factor-1 in immunity and inflammation. Curr Opin Immunol 2006; 18:39-48. (Pubitemid 43049646)
4. Stanley ER, Berg KL, Einstein DB, et al. Biology and action of colony-stimulating factor-1. Mol Reprod Dev 1997; 46:4-10. (Pubitemid 27021347)
5. Wiktor-Jedrzejczak W, Ratajczak MZ, Ptasznik A, Sell KW, Ahmed-Ansari A, Ostertag W. CSF-1 deficiency in the op/op mouse has differential effects on macrophage populations and differentiation stages. Exp Hematol 1992; 20:1004-1010.
6. Hamilton JA. CSF-1 signal transduction. J Leukoc Biol 1997; 62:145-155. (Pubitemid 27380786)
7. Pixley FJ, Stanley ER. CSF-1 regulation of the wandering macrophage: complexity in action. Trends Cell Biol 2004; 14:628-638. (Pubitemid 39440612)
8. Lee AW, States DJ. Colony-stimulating factor-1 requires PI3- kinase-mediated metabolism for proliferation and survival in myeloid cells. Cell Death Differ 2006; 13:1900-1914. (Pubitemid 44542403)
9. Smith JL, Schaffner AE, Hofmeister JK, et al. ets-2 is a target for an akt (protein kinase B)/jun N-terminal kinase signaling pathway in macrophages of motheaten-viable mutant mice. Mol Cell Biol 2000; 20:8026-8034.
10. Lee AW. Synergistic activation of mitogen-activated protein kinase by cyclic AMP and myeloid growth factors opposes cyclic AMP's growth-inhibitory effects. Blood 1999; 93:537-553. (Pubitemid 29035735)
11. Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream. Cell 2007; 129:1261-1274. (Pubitemid 46962095)
12. Varticovski L, Druker B, Morrison D, Cantley L, Roberts T. The colony stimulating factor-1 receptor associates with and activates phosphatidylinositol-3 kinase. Nature 1989; 342:699-702. (Pubitemid 20001589)
13. Datta SR, Brunet A, Greenberg ME. Cellular survival: a play in three Akts. Genes Dev 1999; 13:2905-2927.
14. Sampaio NG, Yu W, Cox D, et al. Phosphorylation of CSF-1R Y721 mediates its association with PI3K to regulate macrophage motility and enhancement of tumor cell invasion. J Cell Sci 2011; 124:2021-2031.
15. Otero K, Turnbull IR, Poliani PL, et al. Macrophage colonystimulating factor induces the proliferation and survival of macrophages via a pathway involving DAP12 and betacatenin. Nat Immunol 2009; 10:734-743.
16. Zhang L, Xing G, Tie Y, et al. Role for the pleckstrin homology domain-containing protein CKIP-1 in AP-1 regulation and apoptosis. EMBO J 2005; 24:766-778. (Pubitemid 40396106)
17. Bosc DG, Graham KC, Saulnier RB, et al. Identification and characterization of CKIP-1, a novel pleckstrin homology domain-containing protein that interacts with protein kinase CK2. J Biol Chem 2000; 275:14295-14306. (Pubitemid 30339711)
18. Safi A, Vandromme M, Caussanel S, et al. Role for the pleckstrin homology domain-containing protein CKIP-1 in phosphatidylinositol 3-kinase-regulated muscle differentiation. Mol Cell Biol 2004; 24:1245-1255. (Pubitemid 38112186)
19. Canton DA, Olsten ME, Kim K, et al. The pleckstrin homology domain-containing protein CKIP-1 is involved in regulation of cell morphology and the actin cytoskeleton and interaction with actin capping protein. Mol Cell Biol 2005; 25:3519-3534. (Pubitemid 40559559)
20. Nie J, Liu L, He F, Fu X, Han W, Zhang L. CKIP-1: a scaffold protein and potential therapeutic target integrating multiple signaling pathways and physiological functions. Ageing Res Rev 2013; 12:276-281.
21. Lu K, Yin X, Weng T, et al. Targeting WW domains linker of HECT-type ubiquitin ligase Smurf1 for activation by CKIP-1. Nat Cell Biol 2008; 10:994-1002.
22. Ling S, Sun Q, Li Y, et al. CKIP-1 inhibits cardiac hypertrophy by regulating class II histone deacetylase phosphorylation through recruiting PP2A. Circulation 2012; 126:3028-3040.
23. Zhang L, Tang Y, Tie Y, et al. The PH domain containing protein CKIP-1 binds to IFP35 and Nmi and is involved in cytokine signaling. Cell Signal 2007; 19:932-944. (Pubitemid 46436434)
24. Juhasz K, Zvara A, Lipp AM, et al. Casein kinase 2-interacting protein-1, an inflammatory signaling molecule interferes with TNF reverse signaling in human model cells. Immunol Lett 2013; 152:55-64.
25. Klappacher GW, Lunyak VV, Sykes DB, et al. An induced Ets repressor complex regulates growth arrest during terminal macrophage differentiation. Cell 2002; 109:169-180. (Pubitemid 34518256)
26. Yang WL, Wang J, Chan CH, et al. The E3 ligase TRAF6 regulates Akt ubiquitination and activation. Science 2009; 325:1134-1138.
27. Lomaga MA, Yeh WC, Sarosi I, et al. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev 1999; 13:1015-1024. (Pubitemid 29200984)
28. Kobayashi N, Kadono Y, Naito A, et al. Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis. EMBO J 2001; 20:1271-1280. (Pubitemid 32233967)
29. Tokuda E, Fujita N, Oh-hara T, et al. Casein kinase 2-interacting protein-1, a novel Akt pleckstrin homology domaininteracting protein, down-regulates PI3K/Akt signaling and suppresses tumor growth in vivo. Cancer Res 2007; 67:9666-9676. (Pubitemid 47621213)
30. Wang Y, Tang Y, Teng L, Wu Y, Zhao X, Pei G. Association of beta-arrestin and TRAF6 negatively regulates toll-like receptor-interleukin 1 receptor signaling. Nat Immunol 2006; 7:139-147. (Pubitemid 43135879)
31. Vallabhapurapu S, Karin M. Regulation and function of NFkappaB transcription factors in the immune system. Annu Rev Immunol 2009; 27:693-733.
32. Pagliari LJ, Perlman H, Liu H, Pope RM. Macrophages require constitutive NF-kappaB activation to maintain A1 expression and mitochondrial homeostasis. Mol Cell Biol 2000; 20:8855-8865. (Pubitemid 32245918)
33. Wang Y, Mo X, Piper MG, et al. M-CSF induces monocyte survival by activating NF-kappaB p65 phosphorylation at Ser276 via protein kinase C. PLoS One 2011; 6:e28081.
34. Lee AW. The role of atypical protein kinase C in CSF-1-dependent Erk activation and proliferation in myeloid progenitors and macrophages. PLoS One 2011; 6:e25580.
35. Frankenberger M, Pforte A, Sternsdorf T, Passlick B, Baeuerle PA, Ziegler-Heitbrock HW. Constitutive nuclear NF-kappa B in cells of the monocyte lineage. Biochem J 1994; 304 (Part 1):87-94.
36. Kuo AH, Stoica GE, Riegel AT, Wellstein A. Recruitment of insulin receptor substrate-1 and activation of NF-kappaB essential for midkine growth signaling through anaplastic lymphoma kinase. Oncogene 2007; 26:859-869.
37. Simoncic PD, Bourdeau A, Lee-Loy A, et al. T-cell protein tyrosine phosphatase (Tcptp) is a negative regulator of colonystimulating factor 1 signaling and macrophage differentiation. Mol Cell Biol 2006; 26:4149-4160. (Pubitemid 43788017)
38. Wynn TA, Chawla A, Pollard JW. Macrophage biology in development, homeostasis and disease. Nature 2013; 496:445-455.
39. Teitelbaum SL, Ross FP. Genetic regulation of osteoclast development and function. Nat Rev Genet 2003; 4:638-649. (Pubitemid 36917505)
40. Cecchini MG, Dominguez MG, Mocci S, et al. Role of colony stimulating factor-1 in the establishment and regulation of tissue macrophages during postnatal development of the mouse. Development 1994; 120:1357-1372. (Pubitemid 24175881)
41. Ryan GR, Dai XM, Dominguez MG, et al. Rescue of the colony-stimulating factor 1 (CSF-1)-nullizygous mouse (Csf1(op)/Csf1(op)) phenotype with a CSF-1 transgene and identification of sites of local CSF-1 synthesis. Blood 2001; 98:74-84.
42. Yoshida H, Hayashi S, Kunisada T, et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 1990; 345:442-444. (Pubitemid 120014957)
43. Dai XM, Ryan GR, Hapel AJ, et al. Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood 2002; 99:111-120.
44. Naito A, Azuma S, Tanaka S, et al. Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice. Genes Cells 1999; 4:353-362. (Pubitemid 29359450)
45. Lamothe B, Webster WK, Gopinathan A, Besse A, Campos AD, Darnay BG. TRAF6 ubiquitin ligase is essential for RANKL signaling and osteoclast differentiation. Biochem Biophys Res Commun 2007; 359:1044-1049. (Pubitemid 46946924)
46. Armstrong AP, Tometsko ME, Glaccum M, Sutherland CL, Cosman D, Dougall WC. A RANK/TRAF6-dependent signal transduction pathway is essential for osteoclast cytoskeletal organization and resorptive function. J Biol Chem 2002; 277:44347-44356. (Pubitemid 36157870)
47. Bai S, Kitaura H, Zhao H, et al. FHL2 inhibits the activated osteoclast in a TRAF6-dependent manner. J Clin Invest 2005; 115:2742-2751. (Pubitemid 41434401)
48. Vremec D, Shortman K. Dendritic cell subtypes in mouse lymphoid organs: cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes. J Immunol 1997; 159:565-573. (Pubitemid 127484204)
49. Shortman K, Caux C. Dendritic cell development: multiple pathways to nature's adjuvants. Stem Cells 1997; 15:409-419. (Pubitemid 27513715)
50. Vremec D, Pooley J, Hochrein H, Wu L, Shortman K. CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J Immunol 2000; 164:2978-2986. (Pubitemid 30148956)
51. Kobayashi T, Walsh PT, Walsh MC, et al. TRAF6 is a critical factor for dendritic cell maturation and development. Immunity 2003; 19:353-363. (Pubitemid 37153412)
52. MacDonald KP, Rowe V, Bofinger HM, et al. The colonystimulating factor 1 receptor is expressed on dendritic cells during differentiation and regulates their expansion. J Immunol 2005; 175:1399-1405. (Pubitemid 41023039)
53. Chow A, Brown BD, Merad M. Studying the mononuclear phagocyte system in the molecular age. Nat Rev Immunol 2011; 11:788-798.
54. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 1995; 378:785-789. (Pubitemid 26004411)